Literature DB >> 25951739

Genetic tests to identify risk for breast cancer.

Julie A Lynch, Vickie Venne, Brygida Berse.   

Abstract

OBJECTIVES: To describe the currently available genetic tests that identify hereditary risk for breast cancer. DATA SOURCES: Systematic review of scientific literature, clinical practice guidelines, and data published by test manufacturers.
CONCLUSION: Changes in gene patent laws and advances in sequencing technologies have resulted in rapid expansion of genetic testing. While BRCA1/2 are the most recognized genes linked to breast cancer, several laboratories now offer multi-gene panels to detect many risk-related mutations. IMPLICATIONS FOR NURSING PRACTICE: Genetic testing will be increasingly important in the prevention, diagnosis, and treatment of breast cancer. Oncology and advanced practice nurses must understand risk factors, significance of various genetic tests, and patient counseling. Published by Elsevier Inc.

Entities:  

Keywords:  BRCA; Breast genetic testing; genetic risk; hereditary risk; multigene panels

Mesh:

Year:  2015        PMID: 25951739      PMCID: PMC4998965          DOI: 10.1016/j.soncn.2015.02.007

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  40 in total

1.  Ten genes for inherited breast cancer.

Authors:  Tom Walsh; Mary-Claire King
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

2.  Hereditary breast and ovarian cancer syndrome.

Authors: 
Journal:  Gynecol Oncol       Date:  2009-04       Impact factor: 5.482

3.  Myriad stands alone.

Authors:  Jacob S Sherkow; Christopher Scott
Journal:  Nat Biotechnol       Date:  2014-07       Impact factor: 54.908

4.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

5.  Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.

Authors:  Francisco J Dominguez; Julie L Jones; Katherina Zabicki; Barbara L Smith; Michele A Gadd; Michele Specht; Daniel B Kopans; Richard H Moore; James S Michaelson; Kevin S Hughes
Journal:  Cancer       Date:  2005-11-01       Impact factor: 6.860

6.  Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: a case series and discussion of BRCA testing modalities.

Authors:  Ann Marie Augustyn; Nicole M Agostino; Tara L Namey; Suresh Nair; Martin A Martino
Journal:  Breast Cancer Res Treat       Date:  2011-05-24       Impact factor: 4.872

7.  Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer.

Authors:  M Robson; M K Dabney; G Rosenthal; S Ludwig; M H Seltzer; T Gilewski; B Haas; M Osborne; L Norton; F Gilbert; K Offit
Journal:  Genet Test       Date:  1997

8.  Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.

Authors:  Kelly A Metcalfe; Aletta Poll; Robert Royer; Marcia Llacuachaqui; Anna Tulman; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

9.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

10.  Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

View more
  8 in total

Review 1.  Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.

Authors:  Christina D Williams; Alyssa Jasmine Bullard; Meghan O'Leary; Reana Thomas; Thomas S Redding; Karen Goldstein
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-08

Review 2.  Genomics-Guided Immunotherapy for Precision Medicine in Cancer.

Authors:  Shradha Mukherjee
Journal:  Cancer Biother Radiopharm       Date:  2019-07-16       Impact factor: 3.099

3.  Genotypes and Haplotypes in the AXIN2 and TCF7L2 Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients.

Authors:  M A Rosales-Reynoso; V Rosas-Enríquez; A M Saucedo-Sariñana; M Pérez-Coria; M P Gallegos-Arreola; E Salas-González; P Barros-Núñez; C I Juárez-Vázquez; S E Flores-Martínez; J Sánchez-Corona
Journal:  Br J Biomed Sci       Date:  2022-01-25       Impact factor: 2.432

4.  Racial and ethnic differences in knowledge and attitudes about genetic testing in the US: Systematic review.

Authors:  Juan R Canedo; Stephania T Miller; Hector F Myers; Maureen Sanderson
Journal:  J Genet Couns       Date:  2019-01-21       Impact factor: 2.537

5.  Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.

Authors:  Maria C Katapodi; Valeria Viassolo; Maria Caiata-Zufferey; Christos Nikolaidis; Nicole Buerki; Karl Heinimann; Viola Heinzelmann-Schwarz; Olivia Pagani; Pierre O Chappuis; Rosmarie Bührer-Landolt; Rossella Graffeo; Henrik Csaba Horváth; Christian Kurzeder; Manuela Rabaglio; Michael Scharfe; Corinne Urech; Tobias E Erlanger; Nicole Probst-Hensch
Journal:  JMIR Res Protoc       Date:  2017-09-20

6.  Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survival.

Authors:  Konrad Buscher; Erik Ehinger; Pritha Gupta; Akula Bala Pramod; Dennis Wolf; George Tweet; Calvin Pan; Charles D Mills; Aldons J Lusis; Klaus Ley
Journal:  Nat Commun       Date:  2017-07-24       Impact factor: 14.919

7.  Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.

Authors:  Maria C Katapodi; Miyeon Jung; Ann M Schafenacker; Kara J Milliron; Kari E Mendelsohn-Victor; Sofia D Merajver; Laurel L Northouse
Journal:  JMIR Cancer       Date:  2018-04-13

8.  Feasibility of genetic testing for cancer risk assessment programme in Nigeria.

Authors:  Prisca O Adejumo; Toyin I G Aniagwu; Olutosin A Awolude; Abiodun O Oni; Olubunmi O Ajayi; Omolara Fagbenle; Dasola Ogungbade; Makayla Kochheiser; Temidayo Ogundiran; Olufunmilayo I Olopade
Journal:  Ecancermedicalscience       Date:  2021-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.